Merck touts 20 new ‘blockbuster’ drugs in development with $50 billion potential
Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.
Fortune19d
Merck’s $8 billion cancer vaccine faces first U.S. jury trial
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Fortune1mon
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Fortune4mon
Belén Garijo
Belén Garijo joined Merck in 2011 as chief operating officer of its biopharma division. She swiftly rose the ranks to CEO of its health care business sector in 2015, before taking the group’s ...